glp 1 type 2 diabetes GLP-1R and Novel GLP-1–Based Medications for Type

Roche reported positive Phase II topline data showing that its once-weekly dual glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist CT-388 achieved substantial, sustained, and dose-dependent weight loss through 48 weeks

Read our full review.

GLP-1 Diet for Women: A Beginners Guide to Understanding GLP-1 and a 5-Step Plan to Naturally Activate It with Recipes & Meal Plans

Clinically guided GLP-1 medication and virtual care Easy access from the HealthEquity app and web portal Tax-advantaged HSA payments for member savings Learn more:

for Half the price

Medicare covers Wegovy, Zepbound, and Foundayo for weight loss starting July 2026